Bio-Techne Ownership | Who Owns Bio-Techne?


OverviewForecastRevenueFinancialsChartTranscripts

Bio-Techne Ownership Summary


Bio-Techne is owned by 35.07% institutional investors, 0.30% insiders, and 64.63% retail investors. Vanguard group is the largest institutional shareholder, holding 11.44% of TECH shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.20% of its assets in Bio-Techne shares.

TECH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBio-Techne35.07%0.30%64.63%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group17.81M11.44%$1.05B
Blackrock14.99M9.53%$1.07B
Blackrock funding, inc. /de12.26M7.87%$640.94M
Morgan stanley8.53M5.48%$445.93M
Fmr7.90M5.07%$412.85M
State street5.87M3.77%$306.68M
Wellington management group llp5.12M3.29%$267.58M
Geode capital management5.11M3.28%$266.80M
Maverick capital4.74M3.04%$247.70M
Invesco4.59M2.94%$239.81M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tradelink capital20.61K13.12%$1.74M
Broadcrest asset management100.00K12.62%$5.56M
Palo ds manager393.57K8.09%$20.57M
Rgm capital2.30M5.39%$127.95M
Montanaro asset management341.05K5.33%$17.82M
Sg capital management1.22M4.23%$63.67M
Alpine peaks capital, lp74.00K3.90%$3.87M
Ruane, cunniff & goldfarb3.39M2.94%$177.27M
American capital management1.02M2.87%$53.36M
Maverick capital4.74M2.86%$247.70M

Top Buyers

HolderShares% AssetsChange
Fmr7.90M0.02%6.88M
Durable capital partners lp4.46M2.40%2.37M
Ruane, cunniff & goldfarb3.39M2.94%1.93M
Norges bank1.69M0.01%1.69M
Capital research global investors3.19M0.03%1.57M

Top Sellers

HolderShares% AssetsChange
Blackrock14.99M0.02%-2.76M
Select equity group709.83K0.19%-2.13M
Price t rowe associates inc /md/2.45M0.01%-1.63M
Ameriprise financial1.71M0.02%-1.09M
Citadel advisors43.40K0.00%-823.32K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.69M0.01%1.69M$99.49M
Vanguard fiduciary trust880.55K0.01%880.55K$46.02M
Alyeska investment group659.05K0.10%659.05K$34.44M
Vanguard global advisers330.50K0.01%330.50K$17.27M
Capital world investors309.76K0.00%309.76K$16.19M

Sold Out

HolderChange
Tfo-tdc-1.00
Tortoise investment management-1.00
Scarborough advisors-2.00
Activest wealth management-2.00
Tfc financial management-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026353-41.75%54,649,691-68.20%350.29%154-47.80%125-39.90%
Dec 31, 2025432-26.90%105,805,616-33.39%670.67%218-30.57%136-26.09%
Sep 30, 2025426-22.83%97,804,424-33.70%620.71%225-23.21%133-31.09%
Jun 30, 2025555-3.31%158,385,865-1.06%1000.97%2945.38%195-5.80%
Mar 31, 2025571-0.52%160,263,9532.30%1011.04%279-4.12%2055.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF5.05M3.20%70.72K
Vanguard Total Stock Mkt Idx Inv4.99M3.19%12.91K
Vanguard Institutional 500 Index Trust4.49M2.87%28.47K
Vanguard 500 Index Investor4.05M2.59%73.04K
Eaton Vance Atlanta Capital SMID-Cap I3.71M2.37%-355.56K
Vanguard Small Cap Index3.60M2.30%-8.53K
Invesco S&P 500® Equal Weight ETF3.15M2.01%-949.00
American Funds SMALLCAP World A2.89M1.85%1.45M
Vanguard Health Care Inv2.46M1.57%-185.56K
Vanguard Explorer Inv2.27M1.45%-25.70K

Recent Insider Transactions


DateNameRoleActivityValue
May 08, 2026Herr Amy E.-Sell$320.39K
Feb 17, 2026Herr Amy E.-Sell$116.79K
Aug 25, 2025Nusse Roeland-Sell$960.39K
Aug 25, 2025BAUMGARTNER ROBERT V-Sell$957.82K
Jun 09, 2025Herr Amy E.-Sell$63.70K

Insider Transactions Trends


DateBuySell
2026 Q2-1
2026 Q1-1
2025 Q4--
2025 Q3-2
2025 Q2-1

TECH Ownership FAQ


Who Owns Bio-Techne?

Bio-Techne shareholders are primarily institutional investors at 35.07%, followed by 0.30% insiders and 64.63% retail investors. The average institutional ownership in Bio-Techne's industry, Biotech Stocks , is 35.75%, which Bio-Techne falls below.

Who owns the most shares of Bio-Techne?

Bio-Techne’s largest shareholders are Vanguard group (17.81M shares, 11.44%), Blackrock (14.99M shares, 9.53%), and Blackrock funding, inc. /de (12.26M shares, 7.87%). Together, they hold 28.84% of Bio-Techne’s total shares outstanding.

Does Blackrock own Bio-Techne?

Yes, BlackRock owns 9.53% of Bio-Techne, totaling 14.99M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 1.07B$. In the last quarter, BlackRock decreased its holdings by -2.758M shares, a -15.54% change.

Who is Bio-Techne’s biggest shareholder by percentage of total assets invested?

Tradelink capital is Bio-Techne’s biggest shareholder by percentage of total assets invested, with 13.12% of its assets in 20.61K Bio-Techne shares, valued at 1.74M$.

Who is the top mutual fund holder of Bio-Techne shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Bio-Techne shares, with 3.20% of its total shares outstanding invested in 5.05M Bio-Techne shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools